Ischemic colitis associated with use of a bitter orange - Containing dietary weight-loss supplement

Shahnaz Sultan, Jeremy Spector, Robert M. Mitchell

Research output: Contribution to journalArticlepeer-review

28 Scopus citations

Abstract

Since the US Food and Drug Administration banned the use of dietary supplements containing ephedra in February 2004, numerous "ephedra- free" weight-loss products have appeared on the market. Many of these supplements contain compounds such as bitter orange that are similar in structure and action to ephedra. We describe a patient in whom ischemic colitis developed 1 week after initiation of a bitter orange - containing weight-loss supplement. The patient had no other predisposing factors, and discontinuation of the supplement led to immediate improvement and ultimate resolution of her symptoms. Both consumers and health care professionals should be aware of the potential harm that bitter orange - containing dietary supplements can cause and report such adverse events to the US Food and Drug Administration.

Original languageEnglish (US)
Pages (from-to)1630-1631
Number of pages2
JournalMayo Clinic Proceedings
Volume81
Issue number12
DOIs
StatePublished - Dec 2006
Externally publishedYes

Bibliographical note

Copyright:
Copyright 2017 Elsevier B.V., All rights reserved.

Fingerprint

Dive into the research topics of 'Ischemic colitis associated with use of a bitter orange - Containing dietary weight-loss supplement'. Together they form a unique fingerprint.

Cite this